In the Media

Boston Magazine reporter Jamie Ducharme writes that MIT researchers have found that blocking the HDAC2 enzyme may potentially reverse memory loss in Alzheimer’s patients. The researchers, “blocked HDAC2 activity by preventing it from binding with Sp3, a protein coding gene that the team found to be a crucial part of genetic blockade formation.”